Lubosan, Dorsido T.
HRN: 03-63-27 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2022
CEFUROXIME 1.5GM (VIAL)
06/27/2022
07/04/2022
IV
1.5gm
Q8
Cholelithiasus
Waiting Final Action